IDH inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IDH inhibitor, covering 2024-07-31 to 2024-07-31. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative Neoplasms [Phase 1]